卡托普利和洛沙坦对大鼠肾脏水通道蛋白-2mRNA和尿液水通道蛋白-2的影响

南方医科大学学报 ›› 2005, Vol. 25 ›› Issue (04): 391-394.

卡托普利和洛沙坦对大鼠肾脏水通道蛋白-2mRNA和尿液水通道蛋白-2的影响

江荣炎, 许顶立, 赖文岩, 任昊, 沈倩波, 邵亚辉

南方医科大学南方医院心内科, 广东, 广州, 510515

出版日期:2005-04-20 发布日期:2005-04-20
基金资助:
收稿日期:2004-11-27。
基金项目:广东省科技计划项目重点课题(2004B30601005);广州市科技攻关计划项目(2004Z3-E0333)
作者简介:江荣炎(1974-),男,主治医师,硕士,E-mail:jiangsh@fimmu.com

Effects of captopril and losartan on expression of kidney aquaporin-2 mRNA and urine aquaporin-2 excretion in rats

JIANG Rong-yan, XU Ding-li, LAI Wen-yan, REN Hao, SHEN Qian-bo, SHAO Ya-hui

南方医科大学南方医院心内科, 广东, 广州, 510515

Online:2005-04-20 Published:2005-04-20

摘要/Abstract

摘要： 目的探讨卡托普利和洛沙坦对正常大鼠肾脏水通道蛋白-2(AQP2)mRNA表达的影响及尿液水通道蛋白-2浓度的改变。方法 30只健康大鼠随机分成3组:正常对照组,卡托普利组,洛沙坦组。经用药后观察血Na⁺、尿量以及尿渗量水平,用RT-PCR半定量检测肾内髓质AQP2及血管加压素2型(V₂)受体mRNA水平,用酶联免疫吸附测定法检测尿液AQP2浓度。结果卡托普利组与洛沙坦组大鼠尿量均较正常组显著增多,卡托普利组尿渗量低于洛沙坦组和正常组,但尿液中AQP2浓度却高于洛沙坦组和正常组。RT-PCR半定量显示卡托普利组AQP2mRNA较正常组显著降低(P<0.05),V₂受体mRNA没有显著差别。结论卡托普利可以抑制正常大鼠肾内髓质AQP2mRNA的表达,同时促进肾内AQP2经尿液排出。

Abstract: Objective To investigate effects of captopril and losartan on the expression of kidney aquaporin-2 (AQP2) mRNA and the excretion of urine AQP2 in rats. Methods Thirty healthy rats were randomized into 3 groups, namely the control group, captopril group and losartan group, respectively. Blood and urine samples were collected from the rats for detecting serum Na⁺, urine volume and urine osmolality in the course of medication. Urine AQP2 concentration was measured by enzyme-linked immunosorbent assay (ELISA). Semi-quantitative RT-PCR was performed for measurement of kidney inner medullary AQP2 and vasopressin V₂ receptor mRNA. Results Urine volume was increased in rats of captopril and losartan groups as compared with that of the control group. However, urine osmolality was lower in captopril group than in the other two groups (P<0.05). RT-PCR revealed decreased quantity of the inner medullary AQP2 mRNA of the captopril group than that of the other two groups, but the quantity of V₂ receptor mRNA did not differ significantly between the 3 groups. Urine AQP2 concentration was significantly higher in captopril group than in the control (P<0.05) and losartan groups (P<0.01). Conclusion Captopril can reduce the expression of the kidney inner medullary AQP2 mRNA and accelerate the excretion of the urine AQP2 in normal rats.

中图分类号:

R334.1

江荣炎, 许顶立, 赖文岩, 任昊, 沈倩波, 邵亚辉. 卡托普利和洛沙坦对大鼠肾脏水通道蛋白-2mRNA和尿液水通道蛋白-2的影响[J]. 南方医科大学学报, 2005, 25(04): 391-394.

JIANG Rong-yan, XU Ding-li, LAI Wen-yan, REN Hao, SHEN Qian-bo, SHAO Ya-hui. Effects of captopril and losartan on expression of kidney aquaporin-2 mRNA and urine aquaporin-2 excretion in rats[J]. Journal of Southern Medical University, 2005, 25(04): 391-394.

参考文献

[1] Nielsen S, Agre P. The aquaporin family of water channels in kidney[J]. Kidney Int, 1995, 48(4): 1057-68.
[2] 许顶立,任昊,MartinPY,等.充血性心力衰竭大鼠肾脏Aqua-porin 2水通道蛋白基因的表达[J].中华医学杂志,1998,78(2):118-20Xu DL,Ren H, Martin PY, et al. Renal aquaporin-2 water channel expression in congestive heart failure rat[J]. Natl Med J Chin, 1998,78(2): 118-20.
[3] 卢武生,许顶立,殷晓燕,等.尿液水通道蛋白-2体夹心ELISA测定法的建立[J].第一军医大学学报,2002,22(6):486-9Lu WS, Xu DL, Yin XY, et al. Enzyme-linked immunosorbent assay for urinary aquaporin-2 water channel protein measurement[J]. J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao, 2002, 22 (6):486-9.
[4] Laski ME, Pressley TA. Aquaporin mediated water flux as a target for diuretic development[J]. Semin Nephrol, 1999, 19(6): 533-50.
[5] Gallardo P, Cid LP, Vio CP, et al. Aquaporin-2, a regulated water channel, is expressed in apical membranes of rat distal colon epithelium[J]. Am J Physiol, 2001, 281 (3): G856-63.
[6] 许顶立,任昊.慢性心力衰竭水潴留机制的研究进展[J].第一军医大学学报(J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao),2001,21(1):65-7.
[7] Hebert PR, Foody JM, Hennekens CH. The renin-angiotensin system:the role of inhibitors, blockers, and genetic polymorphisms in the treatment and prevention of heart failure[J]. Curr Vasc Pharmacol,2003, 1(1): 33-9.
[8] Yu CM, Wing Hon Lai K, Li PS, et al. Normalization of renal aquaporin-2 water channel expression by fosinopril, valsartan, and combination therapy in congestive heart failure: a new mechanism of action[J]. J Mol Cell Cardiol, 2004, 36(3): 445-53.
[9] Staahltoft D, Nielsen S, Janjua NR, et al. Losartan treatment normalizes renal sodium and water handling in rats with mild congestive heart failure[J]. Am J Physiol Renal Physiol, 2002,282(2):F307-15.
[10] Fukuo K. Enhancement of NO bioavailability by ACEI and ARB[J].Nippon Rinsho, 2004, 62(9): 561-6.
[11] Cadnapaphornchai MA, Rogachev B, Summer SN, et al. Evidence for bradykinin as a stimulator of thirst[J]. Am J Physiol Renal Physiol, 2004, 286(5): F875-80.
[12] Murase T, Tian Y, Fang XY, et al. Synergistic effects of nitric oxide and prostaglandins on renal escape from vasopressin-induced antidiuresis[J]. Am J Physiol Regul Integr Comp Physiol, 2003,284(2): R354-62.
[13] Buemi M, Di Pasquale G, Ruello A, et al. Effect ofa prostacyclin analogue, iloprost, on urinary aquaporin-2 excretion in humans[J].Nephron, 2002, 91 (2): 197-202.